SCHEMBL21532389

SCHEMBL21532389

c1ccc(-c2nnc(-c3ccc4c(c3)c3ccccc3n4-c3ccc4oc5ccc(-n6c7ccccc7c7c8oc9ccccc9c8ccc76)cc5c4c3)n2-c2ccccc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.34
HSD17B10 Q99714 4/20 0.34
TSHR P16473 3/20 0.34
POLB P06746 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
BRCA1 P38398 1/20 0.34
KDM4E B2RXH2 4/20 0.33
AVPR1A P37288 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HPGD P15428 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 2/20 0.33
MAPK1 P28482 2/20 0.33
PTGER4 P35408 1/20 0.32
GLA P06280 1/20 0.31
MAPT P10636 2/20 0.31
RGS12 O14924 1/20 0.31
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532801 0.95 ALDH1A1 (0.36) ALDH1A1HSD17B10TSHRPOLBMEN1
SCHEMBL21532616 0.93 ALDH1A1 (0.35) ALDH1A1HSD17B10TSHRPOLBMEN1
SCHEMBL21532546 0.93 ALDH1A1 (0.35) ALDH1A1HSD17B10TSHRPOLBMEN1
SCHEMBL21532379 0.92 ALDH1A1 (0.35) ALDH1A1HSD17B10TSHRPOLBMEN1
SCHEMBL21532387 0.92 AVPR1A (0.36) ALDH1A1HSD17B10TSHRPOLBMEN1
SCHEMBL21532177 0.91 ALDH1A1 (0.36) ALDH1A1HSD17B10TSHRPOLBMEN1
SCHEMBL21532388 0.91 ALDH1A1 (0.32) ALDH1A1HSD17B10TSHRPOLBMEN1
SCHEMBL21532615 0.91 KDM4E (0.36) ALDH1A1HSD17B10TSHRPOLBMEN1
SCHEMBL21532284 0.91 ALDH1A1 (0.35) ALDH1A1HSD17B10TSHRPOLBMEN1
SCHEMBL21532125 0.90 ALDH1A1 (0.35) ALDH1A1HSD17B10TSHRPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 ALDH1A1 158/4885HSD17B10 2103/4885TSHR 3802/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 ALDH1A1 283/4885HSD17B10 2716/4885TSHR 3504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.